Zheng Wang
About Zheng Wang
Zheng Wang is the Associate Director of Precision Medicine at Bristol Myers Squibb, with extensive experience in diagnostic assay development and regulatory compliance.
Company
Zheng Wang currently holds the position of Associate Director, Precision Medicine at Bristol Myers Squibb in LVL, Princeton, NJ. Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Zheng Wang serves as the Associate Director of Precision Medicine, a role that involves leading a team of scientists, managing project timelines and budgets, and coordinating with Quality, Regulatory, Clinical, Manufacturing, and Marketing departments. This role demands strong analytical and problem-solving skills, as well as excellent oral and written communication abilities.
Education and Expertise
Zheng Wang has an extensive academic background and professional expertise. He holds a Ph.D. in Biology/Neuroscience from Brandeis University, an MS in Molecular Biology from the University of Hawaii at Manoa, and a BS in Biology from Fudan University. Additionally, he completed a program in Clinical Trials Design and Management at UCSD Extension. His expertise includes nucleic acid-based and antibody-based diagnostic assay development, achieving CE-mark and FDA 510(k) approval, clinical sample procurement, and inventory management.
Professional Background
Before joining Bristol Myers Squibb, Zheng Wang held several key positions in different companies. He was the Associate Director at OraSure Technologies from 2017 to 2020, and a Project Core Team R&D Technical Lead at Beckman Coulter from 2011 to 2017. From 2007 to 2011, he worked as a Technical Lead/Staff Scientist at GenMark Molecular Diagnostics, Inc., and as a Senior Scientist at Ciphergen Biosystems, Inc. from 2001 to 2007. He began his career as a Postdoctoral Fellow at The J. David Gladstone Institutes/University of California at San Francisco from 1999 to 2001.
Achievements and Skills
Zheng Wang has a proven track record of success in the field of precision medicine and diagnostics. He has developed direct IVD/RUO products, molecular diagnostics, and companion diagnostics, ensuring compliance with regulatory standards like GLP, GMP, and GCP. Wang is highly skilled in PCR-based and antibody-based assay development and has been deeply immersed in the Danaher Business System (DBS), which focuses on efficient project timeline management, problem-solving, and daily task management. His broad range of skills includes clinical studies, 510(k), CE mark approvals, and project management.